Terrapinn's world influenza congress Europe 2009. Part 2
Affiliations
- PMID: 20127556
Item in Clipboard
Terrapinn's world influenza congress Europe 2009. Part 2
IDrugs.
2010 Feb.
Abstract
Terrapinn's World Influenza Congress Europe 2009, held in Brussels, included topics covering new developments in the field of influenza vaccination. This conference report highlights selected presentations on the use of novel technologies for developing vaccines for influenza. Investigational vaccines discussed include Multimeric-001 (BiondVax Pharmaceuticals Ltd), NB-1008 (NanoBio Corp) and an influenza vaccine containing the CAF-01 adjuvant (Statens Serum Institut).
Similar articles
-
Terrapinn's world influenza congress Europe 2009. Part 1.IDrugs. 2010 Feb;13(2):76-7. IDrugs. 2010. PMID: 20127555
-
World Vaccine Congress Lyon - Terrapinn's 11th Annual Congress.IDrugs. 2009 Dec;12(12):738-41. IDrugs. 2009. PMID: 19943212
-
International Drug Discovery Science and Technology--BIT's Seventh Annual Congress.IDrugs. 2010 Jan;13(1):23-5. IDrugs. 2010. PMID: 20024843
-
Recombinant vaccines for influenza virus.Curr Opin Investig Drugs. 2008 Aug;9(8):836-45. Curr Opin Investig Drugs. 2008. PMID: 18666031 Review.
-
The use of inactivated influenza vaccine in children.Semin Pediatr Infect Dis. 2006 Oct;17(4):200-5. doi: 10.1053/j.spid.2006.08.004. Semin Pediatr Infect Dis. 2006. PMID: 17055371 Review.
MeSH terms
Substances
LinkOut - more resources
Medical